Here's a closer look at why Houston should be pushing for a more rapid transition to EVs. Photo via Getty Images

As urban populations increase and more vehicles hit the roads across the United States, the quality of the air is compromised, directly impacting health, environment, and quality of life ― especially for children, minorities, and other vulnerable populations. A 2023 study by Site Selection Group placed Houston at the vanguard of this trend, projecting the metro area to grow nearly 10 percent by 2028, eclipsing 8 million residents.

According to Evolve Houston, a nonprofit working to accelerate EV adoption by bringing together local public and private organizations, residents, and government, the transportation sector emits 47 percent of all greenhouse gas emissions in the Houston area.

In this context, electric vehicles offer a practical solution to mitigate the challenges posed by tailpipe emissions. Their adoption in urban settings has the potential to significantly improve air quality and enhance public health. It’s no wonder the upcoming Houston Auto Show will feature a dedicated EV Pavilion.

Here's a closer look at why Houston should be pushing for a more rapid transition to EVs:

  1. Children’s development is at stake: Early childhood is a critical period for brain development. However, toxic air pollutants can significantly inhibit this growth during these formative years. The consequences include impairing children’s cognitive capabilities in reading and math, akin to missing an entire month of elementary school.
  2. EVs counteract historical racial inequalities: Beyond being an environmental challenge, air pollution is a glaring racial and social justice issue. Areas with fewer White residents suffer almost triple the nitrogen dioxide levels compared to predominantly White zones, as highlighted by the National Academy of Sciences. Historically marginalized communities, often near major traffic corridors, endure heightened pollution exposure. Transitioning to EVs can help address these deeply ingrained environmental inequities.
  3. The health benefits are monumental: A brighter future awaits if EVs become mainstream. According to the American Lung Association, if all new vehicles sold by 2035 are zero-emission, the U.S. could see up to 89,300 fewer premature deaths by 2050. Additionally, asthma attacks might decline by 2 million, saving 10.7 million workdays and resulting in an incredible $978 billion in public health savings.
  4. Global success stories prove the benefits: The impact of mass EV adoption has already been demonstrated outside the U.S. For instance, Norway has seen a notable reduction in dangerous particle emissions since 87 percent of its new car sales are now fully electric. Likewise, California’s adoption of electric vehicles correlated with a 3.2% decrease in asthma-related ER visits between 2013 and 2019.
  5. Cities have the power and means to lead the way: Many global cities are trailblazers in the electric transition. New York City, with more than 4,000 government-owned EVs, is a prime example. Moreover, by electrifying their take-home fleets, cities can set a precedent for their communities. Seeing neighbors drive electric vehicles daily serves as a powerful endorsement, motivating nearby residents to make the switch. Incentives like public charging stations, free parking for EVs, rebates for home charger installations, reimbursing for charging at home, and reduced tolls, further bolster this movement.

Houstonians stand at a pivotal juncture. The choices made today concerning transportation will profoundly influence the health and well-being of residents tomorrow. The shift to electric vehicles is more than just an eco-friendly choice; it's a commitment to a brighter, cleaner future. By leading with action and vision, cities can create a legacy that upcoming generations will appreciate and thrive in.

------

Kate L. Harrison is the co-founder and head of marketing at MoveEV, an AI-backed EV transition company that helps organizations convert fleet and employee-owned gas vehicles to electric, and reimburse for charging at home.

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”